Skip to main content
Clinical Trials/NCT04111354
NCT04111354
Completed
Not Applicable

Early Mobilization After Pacemaker Implantation.

Charles University, Czech Republic1 site in 1 country200 target enrollmentMarch 28, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pacemaker Complication
Sponsor
Charles University, Czech Republic
Enrollment
200
Locations
1
Primary Endpoint
Composite endpoint of incidence of adverse events from secondary outcomes depending on the length of immobilization (early vs. late).
Status
Completed
Last Updated
last year

Overview

Brief Summary

Permanent pacemaker implantation is one of the most common arrhythmological procedure. This procedure is usually accompanied by a minimum of 2-3 days hospitalization, with immobilization of patients (supine) for 16-24 hours. The optimal duration of patient´s immobilization is not determined. There is also no recommendation from individual manufacturers of pacemakers for the duration of immobilization after pacemaker implantation. The length of immobilization is based rather on the tradition established at the time of using electrodes with passive fixation. The aim of our prospective, randomized study (EMAPI) is to compare the safety of short-term (4-hours) immobilization with long-term (16-24 hours) immobilization after primary pacemaker implantation. Septal position will be used for right ventricular electrode.

Registry
clinicaltrials.gov
Start Date
March 28, 2019
End Date
August 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Charles University, Czech Republic
Responsible Party
Principal Investigator
Principal Investigator

Jiri Smid

M.D.

Charles University, Czech Republic

Eligibility Criteria

Inclusion Criteria

  • 18 years and older.
  • Indication for permanent pacemaker implantation.
  • Mobile and compliant patient.
  • Willing and able to give written informed consent.

Exclusion Criteria

  • Imobile and noncompliant patient.
  • Indication of CRT implantation.
  • Upgrade or revision of implanted devise.
  • Contraindications to pacemaker implantation.

Outcomes

Primary Outcomes

Composite endpoint of incidence of adverse events from secondary outcomes depending on the length of immobilization (early vs. late).

Time Frame: 6 months

Comparsion of incidence of dislodgement of atrial electrode, dislodgement of ventricular electrode in septal position, hematoma surgically treated or requiring blood transfusions, pneumothorax, pocket infection, others complications

Secondary Outcomes

  • Incidence of hematoma (surgically treated or requiring blood transfusions.)(6 months)
  • Incidence of atrial lead dislodgement.(6 months)
  • Incidence of ventricular lead dislodgement.(6 months)
  • Incidence of pneumothorax.(24 hours)
  • Incidence of pocket infection.(6 months)
  • Incidence of others complications.(6 months)

Study Sites (1)

Loading locations...

Similar Trials